Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Apr 2024. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5310135017 | Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5310136016 | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5310135017 | Product containing only emtricitabine and rilpivirine and tenofovir in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5310136016 | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet | Is a | True | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet | Is a | True | Emtricitabine and rilpivirine and tenofovir only product in oral dose form | Inferred relationship | Existential restriction modifier (core metadata concept) |
This concept is not in any reference sets